United States Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2030

The United States Vaccines Market is poised to reach a value of more than US$ 26.1 billion by 2026.

United States Vaccines Market Overview

The report study researched by Esticast Research gives comprehensive knowledge and valuable insights about the United States Vaccines Market. Also, the study attempts to deliver significant and detailed insights into the current market prospect and emerging growth scenarios. The report on the United States Vaccines Market also emphasizes on market players as well as the new entrants in the market landscape. The United States Vaccines Market is poised to reach a value of more than US$ 26.1 billion by 2026. The United States Vaccines Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide United States Vaccines Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the United States Vaccines industry. Impact of Coronavirus (COVID-19) on United States Vaccines Market. Coronavirus (COVID-19) is spreading across the world with a serious impact on the economy and the global market. The report considers and accounts for the impact of COVID-19 on United States Vaccines Market across all the segments, regions, countries, and key players. North America and Europe are worst-hit countries by Coronavirus which are key players in the global economy. The report provides a detailed analysis of the impact on the market, growth strategies, supply china disruption, consumption pattern of the United States Vaccines Market.

Market Segmentation

The report provides market size with 2019 as the base year in consideration and a yearly forecast until 2026 in terms of Revenue (USD Million). The estimates for all segments including type and application have been provided on a regional basis for the forecast period mentioned above. We have implemented a mix of top-down and bottom-up approaches for market sizing, analyzing the key regional markets, dynamics, and trends for various applications. The United States Vaccines Market has been estimated by integrating the regional markets. United States Vaccines Market by Key Segments: The following 27 leading vaccines of the united states vaccines market are detailed with market size and seven-years forecast • Prevnar / Prevnar 13 • Gardasil / Gardasil 9 • Fluzone • Flublok • Flucelvax Quadrivalent • Afluria Quadrivalent • Fluad • Varivax • Menactra • Proquad • Pneumovax 23 • Fluarix/FluLaval • Havrix/Twinrix/Engerix–B • M–M–R II • Adacel • Boostrix • Bexsero • Menveo • Trumenba • Shingrix • Pentacel • Recombivax HB • Rotateq • Rotarix • Pediarix/Infanrix • Heplisav–B • TDVAX Competitive Landscape: Key players profile in the report include
  • Sanofi Pasteur
  • Business Overview
  • Promising Vaccines in the Clinical Development
  • Recent Development
  • GlaxoSmithKline (GSK)
  • Merck
  • Pfizer
  • Dynavax Technologies Corporation
  • Grifols
The report of United States Vaccines Market studies the key players present in the market. The chapter includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies, and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected year. In addition to a brief overview of the company, analysts shed light on their valuation and evolution. It also discusses the list of important products and the ones in the pipeline. The competitive landscape is analyzed by understanding the approaches of the companies and the initiatives they have taken in recent years to triumph over the intensive competition. Frequently Asked Questions (FAQ):
  • What is the size of the United States Vaccines Market?
  • How much will this market be worth from 2020 to 2030?
  • What are the major deals happenings in the United States Vaccines Market?
  • Which country is expected to hold the highest market share in the United States Vaccines Market?
  • What are production processes, major issues, and solutions to mitigate the development risk?
  • Who are the top players and what are their activities, revenue, recent developments, and prospects?
  • What are the main drivers and restraints in the United States Vaccines Market?
  • Which are the largest revenue generating products, services or regions and their comparative growth rate?

1. Executive Summary

2. United States Vaccines Market Size & Forecast (2015 - 2030)

3. United States Vaccines Market Share & Y-o-Y Growth (%), 2017 - 2030

4. United States Vaccines Market - Key Market Dynamics
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. United States Leading 27 Vaccines Market Assessment & Opportunity (Value), 2015 - 2030
5.1 Prevnar/Prevnar 13
5.2 Gardasil/Gardasil 9
5.3 Fluzone
5.4 Flublok
5.5 Flucelvax Quadrivalent
5.6 Afluria Quadrivalent
5.7 Fluad
5.8 Varivax
5.9 Menactra
5.10 Proquad
5.11 Pneumovax 23
5.12 Fluarix/FluLaval
5.13 Havrix/Twinrix/Engerix-B
5.14 M-M-R II
5.15 Adacel
5.16 Boostrix
5.17 Bexsero
5.18 Menveo
5.19 Trumenba
5.20 Shingrix
5.21 Pentacel
5.22 Recombivax HB
5.23 Rotateq
5.24 Rotarix
5.25 Pediarix/Infanrix
5.26 Heplisav-B
5.27 TDVAX
5.28 Other Vaccines

6. United States Vaccines Pricing Trends & Analysis

7. Regulatory Framework of the United States Vaccines Market

8. Major Deals and Agreement Happenings in the Vaccines Market
8.1 Collaboration Deal
8.2 Licensing Agreement
8.3 Exclusive Agreement
8.4 Distribution Agreement
8.5 Partnerships

9. Key Players in the United States Vaccines Market
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Promising Vaccines in the Clinical Development
9.1.3 Recent Development
9.2 GlaxoSmithKline (GSK)
9.2.1 Business Overview
9.2.2 Vaccines Portfolio
9.2.3 Promising Vaccines in the Clinical Development
9.2.4 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Vaccines Portfolio
9.3.3 Promising Vaccines in the Clinical Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Vaccines Portfolio
9.4.3 Promising Vaccines in the Clinical Development
9.4.4 Recent Development
9.5 Dynavax Technologies Corporation
9.5.1 Business Overview
9.5.2 Vaccines Portfolio
9.5.3 Promising Vaccines in the Clinical Development
9.5.4 Recent Development
9.6 Grifols
9.6.1 Business Overview
9.6.2 Vaccines Portfolio
9.6.3 Recent Development

List of Tables
Table 3-1: United States Vaccines Market Share & Y-o-Y Growth (Percent), 2017 - 2018
Table 3-2: United States Vaccines Market Share & Y-o-Y Growth Forecast (Percent), 2019 - 2030
Table 6-1: United States Adult Vaccines Price, 2019 - 2020
Table 6-2: United States Adult Influenza Vaccines Price, 2019 - 2020
Table 6-3: United States Pediatric Vaccines Price, 2019 - 2020
Table 6-4: United States Pediatric Influenza Vaccines Price, 2019 - 2020
Table 7-1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 8-1: Merger & Acquisitions in the Vaccines Market
Table 8-2: Collaboration Deal in the Vaccines Market
Table 8-3: Licensing Agreement in the Vaccines Market
Table 8-4: Exclusive Agreement in the Vaccines Market
Table 8-5: Distribution Agreement in the Vaccines Market
Table 8-6: Partnerships in the Vaccines Market
Table 9-1: Sanofi Promising Vaccines in the Clinical Development
Table 9-2: GSK Promising Vaccines in the Clinical Development
Table 9-3: Merck Promising Vaccines in the Clinical Development
Table 9-4: Pfizer Promising Vaccines in the Clinical Development
Table 9-5: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development

List of Figures
Figure 2-1: United States Vaccines Market Size (Million US$), 2015 - 2018
Figure 2-2: United States Vaccines Market Size Forecast (Million US$), 2019 - 2030
Figure 5-1: United States Prevnar/Prevnar 13 Market Value (Million US$), 2015 - 2018
Figure 5-2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$), 2019 - 2030
Figure 5-3: United States Gardasil/Gardasil 9 Market Value (Million US$), 2015 - 2018
Figure 5-4: United States Gardasil/Gardasil 9 Market Value Forecast (Million US$), 2019 - 2030
Figure 5-5: United States Fluzone Market Value (Million US$), 2015 - 2018
Figure 5-6: United States Fluzone Market Value Forecast (Million US$), 2019 - 2030
Figure 5-7: United States Fluzone Market Value & Forecast (Million US$), 2018 - 2030
Figure 5-8: United States Flucelvax Quadrivalent Market Value (Million US$), 2016 - 2018
Figure 5-9: United States Flucelvax Quadrivalent Market Value Forecast (Million US$), 2019 - 2030
Figure 5-10: United States Afluria Quadrivalent Market Value (Million US$), 2016 - 2018
Figure 5-11: United States Afluria Quadrivalent Market Value Forecast (Million US$), 2019 - 2030
Figure 5-12: United States Fluad Market Value (Million US$), 2016 - 2018
Figure 5-13: United States Fluad Market Value Forecast (Million US$), 2019 - 2030
Figure 5-14: United States Varivax Market Value (Million US$), 2015 - 2018
Figure 5-15: United States Varivax Market Value Forecast (Million US$), 2019 - 2030
Figure 5-16: United States Menactra Market Value (Million US$), 2015 - 2018
Figure 5-17: United States Menactra Market Value Forecast (Million US$), 2019 - 2030
Figure 5-18: United States Proquad Market Value (Million US$), 2015 - 2018
Figure 5-19: United States Proquad Market Value Forecast (Million US$), 2019 - 2030
Figure 5-20: United States Pneumovax 23 Market Value (Million US$), 2015 - 2018
Figure 5-21: United States Pneumovax 23 Market Value Forecast (Million US$), 2019 - 2030
Figure 5-22: United States Fluarix/FluLaval Market Value (Million US$), 2015 - 2018
Figure 5-23: United States Fluarix/FluLaval Market Value Forecast (Million US$), 2019 - 2030
Figure 5-24: United States Havrix/Twinrix/Engerix-B Market Value (Million US$), 2015 - 2018
Figure 5-25: United States Havrix/Twinrix/Engerix-B Market Value Forecast (Million US$), 2019 - 2030
Figure 5-26: United States M-M-R ll Market Value (Million US$),2015 - 2018
Figure 5-27: United States M-M-R ll Market Value Forecast (Million US$),2019 - 2030
Figure 5-28: United States Adacel Market Value (Million US$),2015 - 2018
Figure 5-29: United States Adacel Market Value Forecast (Million US$),2019 - 2030
Figure 5-30: United States Boostrix Market Value (Million US$),2015 - 2018
Figure 5-31: United States Boostrix Market Value Forecast (Million US$),2019 - 2030
Figure 5-32: United States Bexsero Market Value (Million US$),2015 - 2018
Figure 5-33: United States Bexsero Market Value Forecast (Million US$),2019 - 2030
Figure 5-34: United States Menveo Market Value (Million US$),2015 - 2018
Figure 5-35: United States Menveo Market Value Forecast (Million US$), 2019 - 2030
Figure 5-36: United States Trumenba Market Value (Million US$),2017 - 2018
Figure 5-37: United States Trumenba Market Value Forecast (Million US$), 2019 - 2030
Figure 5-38: United States Shingrix Market Value (Million US$),2017 - 2018
Figure 5-39: United States Shingrix Market Value Forecast (Million US$), 2019 - 2030
Figure 5-40: United States Pentacel Market Value (Million US$), 2015 - 2018
Figure 5-41: United States Pentacel Market Value Forecast (Million US$), 2019 - 2030
Figure 5-42: United States Recombivax HB Market Value (Million US$), 2015 - 2018
Figure 5-43: United States Recombivax HB Market Value Forecast (Million US$), 2019 - 2030
Figure 5-44: United States Rotateq Market Value (Million US$), 2015 - 2018
Figure 5-45: United States Rotateq Market Value Forecast (Million US$), 2019 - 2030
Figure 5-46: United States Rotarix Market Value (Million US$),2015 - 2018
Figure 5-47: United States Rotarix Market Value Forecast (Million US$), 2019 - 2030
Figure 5-48: United States Pediarix/Infanrix Market Value (Million US$), 2015 - 2018
Figure 5-49: United States Pediarix/Infanrix Market Value Forecast (Million US$), 2019 - 2030
Figure 5-50: United States Heplisav-B Market Value & Forecast (Million US$), 2018 - 2030
Figure 5-51: United States TDVAX Market Value (Million US$), 2016 - 2018
Figure 5-52: United States TDVAX Market Value Forecast (Million US$), 2019 - 2030
Figure 5-53: United States Other Vaccines Market Value (Million US$), 2015 - 2018
Figure 5-54: United States Other Vaccines Market Value Forecast (Million US$), 2019 - 2030

Key players profile in the report include
  • Sanofi Pasteur
  • Business Overview
  • Promising Vaccines in the Clinical Development
  • Recent Development
  • GlaxoSmithKline (GSK)
  • Merck
  • Pfizer
  • Dynavax Technologies Corporation
  • Grifols

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS